Paper
24 March 2023 Current treatment of autism spectrum disorder
Jiayang Xu
Author Affiliations +
Proceedings Volume 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022); 126113K (2023) https://doi.org/10.1117/12.2669675
Event: International Conference on Biological Engineering and Medical Science (ICBioMed2022), 2022, Oxford, United Kingdom
Abstract
Autism spectrum disorder (ASD) is a neurological and developmental disorder that affects 62 out of every 10,000 people with ASD in addition to intellectual and cognitive impairment. It is usually observed in infancy and early childhood. ASD is a very complex disease. Making the most of it could lead to better treatments and help many families with their challenges. ASD, however, is currently incurable. The primary methods of treating ASD are managing its symptoms and utilizing a variety of therapy to help people. The study's findings revealed that while the main way of ASD treatment is risperidone and aripiprazole, only for the management of the purpose of the disorder's agitation has FDA licensed them. Hence, some clinical trials had evaluated several pharmacological treatments and associated PDDs. They have also provided clinicians with access to a wide range of off-label options. Given the potential risks and benefits, these treatments should be provided in line with each patient's unique needs. In sum, this review will cover the causes, symptoms, and potential treatments for ASD.
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Jiayang Xu "Current treatment of autism spectrum disorder", Proc. SPIE 12611, Second International Conference on Biological Engineering and Medical Science (ICBioMed 2022), 126113K (24 March 2023); https://doi.org/10.1117/12.2669675
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Diseases and disorders

Genetics

Proteins

Brain

Magnesium

Neurological disorders

Brain diseases

RELATED CONTENT

The causes of schizophrenia in adolescents
Proceedings of SPIE (March 24 2023)
The role of NRG1 in schizophrenia
Proceedings of SPIE (March 24 2023)
Diagnosis and treatment for Huntington’s disease
Proceedings of SPIE (September 07 2023)

Back to Top